Found 628 chains in Genus chains table. Displaying 301 - 350. Applied filters: Proteins

Search results query: antiviral protein

Total Genus Sequence Length pdb Title
38 182 8cnyA Structure of enterovirus a71 3c protease
38 182 8cnxA Structure of enterovirus d68 3c protease
2 8 7yueC Epitope-directed anti-sars cov 2 scfv engineered against the key spike protein region.
59 239 7yueA Epitope-directed anti-sars cov 2 scfv engineered against the key spike protein region.
213 1126 7zrvA Cryo-em structure of omicron spike in complex with de novo designed binder, full map
178 1120 7zssA Cryo-em structure of d614 spike in complex with de novo designed binder
30 196 7zsdM Cryo-em structure of omicron spike in complex with de novo designed binder, local
22 65 7zsdP Cryo-em structure of omicron spike in complex with de novo designed binder, local
22 65 7zrvE Cryo-em structure of omicron spike in complex with de novo designed binder, full map
20 65 7zssD Cryo-em structure of d614 spike in complex with de novo designed binder
28 271 8d48A Sd1.040 fab in complex with sars-cov-2 spike 2p glycoprotein
26 220 8d48L Sd1.040 fab in complex with sars-cov-2 spike 2p glycoprotein
23 223 8d48H Sd1.040 fab in complex with sars-cov-2 spike 2p glycoprotein
45 211 8dxtL Fab arm of antibody gar12 bound to the receptor binding domain of sars-cov-2.
38 196 8dxuR Fab arms of antibodies gar03 and 10g4 bound to the receptor binding domain of sars-cov-2 in a 1:1:1 complex.
45 223 8dxtH Fab arm of antibody gar12 bound to the receptor binding domain of sars-cov-2.
46 212 8dxuL Fab arms of antibodies gar03 and 10g4 bound to the receptor binding domain of sars-cov-2 in a 1:1:1 complex.
42 221 8dxuA Fab arms of antibodies gar03 and 10g4 bound to the receptor binding domain of sars-cov-2 in a 1:1:1 complex.
46 196 8dxtR Fab arm of antibody gar12 bound to the receptor binding domain of sars-cov-2.
39 213 8dxuB Fab arms of antibodies gar03 and 10g4 bound to the receptor binding domain of sars-cov-2 in a 1:1:1 complex.
42 219 8dxuH Fab arms of antibodies gar03 and 10g4 bound to the receptor binding domain of sars-cov-2 in a 1:1:1 complex.
36 194 7x4iA Crystal structure of nanobody asa3 in complex with dimer sars-cov-1 rbd
89 386 7wjqB Crystal structure of gsdmb in complex with ipah7.8
21 123 7x4iE Crystal structure of nanobody asa3 in complex with dimer sars-cov-1 rbd
76 240 7wjqA Crystal structure of gsdmb in complex with ipah7.8
48 232 8d47B Fp.006 fab in complex with sars-cov-2 fusion peptide
5 18 8d47C Fp.006 fab in complex with sars-cov-2 fusion peptide
51 213 8d47A Fp.006 fab in complex with sars-cov-2 fusion peptide
293 1777 7zoqB Cryo-em structure of a crispr effector in complex with a caspase regulator
91 301 7zv7A Crystal structure of sars cov-2 main protease in complex with an inhibitor 57
82 305 7zv8A Crystal structure of sars cov-2 main protease in complex with an inhibitor 58
116 434 7t5pA Cryo-em structure of human simc1-slf2 complex
122 426 7t5pB Cryo-em structure of human simc1-slf2 complex
213 821 7zoqA Cryo-em structure of a crispr effector in complex with a caspase regulator
87 301 7zv5A Crystal structure of sars cov-2 main protease in complex with an inhibitor 4
62 178 7z56AAA Crystal structure of the ring nuclease 0455 from sulfolobus islandicus (sis0455) in its apo form
56 188 7z55AAA Crystal structure of the ring nuclease 0455 from sulfolobus islandicus (sis0455) in complex with its substrate
9 40 7zr2B Crystal structure of a chimeric protein mimic of sars-cov-2 spike hr1 in complex with hr2
110 227 7zr2A Crystal structure of a chimeric protein mimic of sars-cov-2 spike hr1 in complex with hr2
27 117 8gptD Yfv_e_yd6scfv_postfusion
21 112 8gptE Yfv_e_yd6scfv_postfusion
74 392 8gpuA Yfv_e_yd6fab_prefusion
49 392 8gpxE Yfv_e_yd73fab_postfusion
35 214 8gpxL Yfv_e_yd73fab_postfusion
35 213 8gpuD Yfv_e_yd6fab_prefusion
67 397 8gptA Yfv_e_yd6scfv_postfusion
28 226 8gpxH Yfv_e_yd73fab_postfusion
33 216 8gpuC Yfv_e_yd6fab_prefusion
26 98 7wbnA Pdb structure of revcc
74 305 8a4tA Crystal structures of diastereomer (s,s,s)-13b (13b-k) in complex with the sars-cov-2 mpro